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Key words: TBI; microglia; gender; sex; sex differences; inflammation Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality worldwide. In 2010, the Centers for Disease Control and Prevention (CDC) reported that TBI accounted for approximately 2.2 million emergency department visits, 283,000 hospitalizations, and over 52,000 deaths in the United States (Faul et al., 2010; Prevention, 2015) . TBI is a major cause of long-term disability, leading to chronic suffering for patients and their families; furthermore, in the United States alone, the estimated costs of TBI to society exceed $60 billion yearly (Coronado et al., 2012) , but a successful treatment option is still lacking.
As a result, TBI has been the subject of great amounts of attention and research, both in the laboratory and at the bedside, over the last 2 decades. However, most data come from male subjects or lack a separation of gender, thus overlooking potentially important differences between males and females, especially with respect to treatment outcomes (Hirschberg, 2008) . There are definite anatomical, developmental, and physiologic differences of the central nervous system (CNS) between the sexes (McCarthy et al., 2012 . Thus, it stands to reason that TBI-as in stroke-differs between men and women, and ignoring this possibility could lead to obfuscation of data and unnecessary harm to patients (Wagner et al., 2004; Vagnerova et al., 2008; Bodhankar et al., 2015) .
On a cellular level, TBI causes a secondary inflammatory response within the CNS that leads to neurological deficits, both motor and cognitive, beyond that caused by the primary injury (Sandhir et al., 2008; Ramlackhansingh et al., 2011) . Microglia, the macrophages of the CNS, play a crucial role in this inflammatory response and are, therefore, the target of multiple preclinical and clinical treatment trials (Nakajima and Kohsaka, 2001; Bedi et al., 2013; Savitz and Cox, 2016) . Again, however, SIGNIFICANCE Traumatic brain injury (TBI) affects more than 2 million people in the United States each year, with mortality near or above 50,000 people. Males represent a higher percentage of TBI-related mortality, and females are underrepresented in TBI preclinical and clinical research. Much of the pathology is secondary to the inflammatory response primarily induced by microglia. Sex differences exist in the role of microglia in brain development and other neurologic disorders, yet the majority of animal studies of microglia and TBI only use male subjects. It is crucial to examine the relationship between sex, microglia and TBI. most animal studies of microglia and TBI have focused on male subjects. Only recently have investigators begun to shift this paradigm. Understanding the role of microglia in TBI with respect to sex is central to evaluating the effectiveness and potential harm of future treatment strategies that aim to attenuate microglial-mediated inflammation. This Review attempts to briefly outline what is currently known about TBI with respect to sex differences at clinical and preclinical levels, with specific emphasis on microglia.
EPIDEMIOLOGY AND GENDER DIFFERENCES According to the CDC, TBI accounts for 16% of all injury-related hospitalizations, and up to one-third of all injury-related deaths had TBI listed as a direct or underlying cause of death (Prevention CfDCa, 2015) . Gender differences do exist with respect to the incidence of and mortality caused by TBI. The overall death rate of TBI is roughly three times higher for males (28.8 per 100,000 population) than for females (9.1 per 100,000 population), with the largest gap occurring between ages 20 and 24 years (40.7 for males vs. 9.4 for females; Coronado et al., 2011) . Overall, males account for the majority of all TBIrelated medical visits (Faul et al., 2010; Cuthbert et al., 2015) , probably because of the increased propensity of males to partake in activities and risky behavior that lend themselves to TBI, although this dichotomy may be changing as females become more involved in military combat, contact sports, etc. (Marar et al., 2012; Amara et al., 2014; McGlade et al., 2015) .
In studying the characteristics of 20,000 patients aged 16 years and older receiving acute inpatient rehabilitation for TBI between 2001 and 2010, Cuthbert et al. (2015) found that males represented 64.3% of the total population. Males certainly constituted the majority of these patients between aged 16 and 19 years (67.2% male vs. 32.8% female) up to age 60-69 years (65.4% male vs. 34.6% female), accounting for over 70% of patients aged 20-59 years; however, the gap between genders narrowed for patients aged between age 70 and 79 years (54.9% male vs. 45.1% female) and even more so for patients older than age 80 years (51.6% male vs. 48.4% female; Cuthbert et al., 2015) . For children, both male and female, trauma is the leading cause of death, and TBI is the leading cause of trauma-related morbidity and disability (Stanley et al., 2012) . However, males represent a significant majority of TBI-related emergency departments visits, hospitalizations, and deaths among the pediatric population (Prevention, 2015) . In studying the effects of endogenous hormones on pediatric patients suffering from TBI, Ley et al. (2013) found that the rates of TBI were higher among males than females in both the prepubescent and the pubescent cohorts. However, pubescent patients were more likely to be male in comparison with prepubescent patients (71.6% vs. 61.9%), indicating that hormonal differences might be a contributing factor for reduced mortality in pubescent females (Ley et al., 2013) .
Males represent a larger percentage of TBI patients then females; however, they are disproportionately represented in preclinical and clinical research data (Hirschberg, 2008; Colantonio et al., 2010; Scott et al., 2015) . TBI is still a major cause of morbidity and mortality among females, especially children and the elderly. Therefore, females should be represented in clinical trials and data.
GENDER DIFFERENCES IN CLINICAL
OUTCOMES Males represent a majority of TBI-related deaths by roughly 3:1; however, only recently has research begun to evaluate whether gender has an influence in outcomes after TBI, including mortality, functionality, and behavioral sequelae (Colantonio et al., 2010; Coronado et al., 2011; Scott et al., 2015) . It is well known that TBI is a heterogeneous disease and can affect many aspects of a patient's life; however, the differences in functional and behavioral outcomes between males and females are important to note in future clinical trials and therapeutic evaluations.
MORBIDITY AND MORTALITY
There is conflicting evidence on whether sex has an effect on mortality after TBI. In preclinical models, female rats in the proestrus stage of their cycle demonstrated improved outcomes and decreased cerebral edema after TBI in comparison with male rats (Roof and Hall, 2000b) . Estrogen can act directly on neurons and glial cells, potentially affecting behavior and CNS immune function after TBI (Bruce-Keller et al., 2000) . Because female hormones, estrogen and progesterone, may confer neuroprotection after TBI, gender and menarche status have been examined as potential factors effecting survival. One retrospective review of over 72,000 patients with moderate to severe TBI demonstrated that perimenopausal (aged 46-55 years) and postmenopausal (aged 55 years and older) females had significantly lower risk of mortality than males, but premenopausal females had no mortality advantage over age-matched males (Berry et al., 2009) . Coimbra et al. (2003) reviewed records from 914 women and 916 men and found no statistically significant differences in mortality between males and females suffering from mild, moderate, or severe TBI. Furthermore, to control for effects of menopause, the authors excluded all patients over age 50 years and again found no differences in survival (Coimbra et al., 2003) . These studies seem to contradict the hypothesis that female hormones confer protection after TBI.
It has been suggested that the pediatric population might provide a better study population than adults because of the potentially confounding effects of variability in the age of menopause and length of the perimenopausal period (Phelan et al., 2007) . Thus, researchers have studied gender differences in mortality between prepubescent, in which the hypothalamic-pituitary-gonadal axis is quiescent in both males and females, vs. postpubescent children and young adults. Ley et al. (2013) reviewed 20,280 patients aged 0-18 years with moderate to severe TBI, studying the effects of puberty and gender on outcomes after TBI. They found that female sex did not predict lower mortality in the prepubescent group; however in the pubescent group, female sex was associated with reduced mortality. Furthermore, although not specifically focusing on TBI, Phelan et al. (2007) examined the records of 218,000 patients from 0 to 20 years of age from the National Trauma Database and stratified the population by age: prepubertal (birth to 8 years), peripubertal (8.1-14 years) and postpubertal (14.1-20 years). First, males and females had similar rates of severe TBI relative to overall TBI, which would contradict the possibility that differences in injury severity or higher rates of males suffering TBI lead to the disproportionate number of male TBI deaths. In addition, the authors found that female sex was associated with improved survival rates in the postpubescent patients in a manner directly proportional to severity of injury; i.e., the survival advantage of the female gender was most pronounced when the injuries were severe and was only modest or negligible for moderate or mild injuries, respectively. The prepubertal and peripubertal age groups showed no difference in survival rates between genders, and the data for overall survival differences between genders was not presented (Phelan et al., 2007) . Thus, the data from the pediatric population, who have fewer confounding comorbidities than adults, suggests that postpubescent females may indeed have a survival advantage over males after severe TBI.
Patient outcomes are another important consideration for assessing the efficacy of potential therapies after TBI. If sex does play a role in overall outcome, then overlooking this fact would certainly confound any results or data from clinical trials. Coimbra et al. (2003) found no difference between males and females in incidence of pneumonia, adult respiratory distress syndrome, or sepsis after TBI. However, Berry et al. (2009) found that female patients had significantly fewer complications, shorter hospital stays, and shorter intensive care unit (ICU) stays than male patients after moderate to severe TBI. The authors state that estrogen was unlikely the source of improved female outcomes, noting that peri-and postmenopausal females demonstrated increased survival, whereas premenopausal females did not (Berry et al., 2009) . However, among the pediatric population, although postpubescent females had reduced mortality, they also had higher ICU admission rates, longer ICU length of stay (LOS), and longer mean hospital LOS than age-matched males (Ley et al., 2013) .
A summary of findings from these studies is given in Table I . Taken together, the findings indicate that sex does appear to play a role in morbidity and mortality after TBI; however, the role that sex hormones play is unclear and deserves further study.
PHYSIOLOGIC MARKERS
In a study of sex differences in cerebral spinal fluid (CSF) markers after TBI in humans, Wagner et al. (2004) concluded that the interrelationships among excitotoxicity, ischemia, and oxidative injury were different between male and female patients with severe TBI. Assessing CSF levels of F2-isoprostane (a marker of lipid peroxidation), glutamate (a marker of excitotoxicity), and lactate/ pyruvate (markers of ischemia) on days 1, 2, and 3 postinjury, the authors found significant gender effects on F2-isoprostane/glutamate and F2-isoprostane/lactate/ pyruvate ratios, relative indexes of the degree of oxidative damage for a particular excitotoxic load and ischemic insult, respectively. Temporally, the ratios increased for males over days 1-3, although they decreased in females; furthermore, their data suggested that excitotoxic and ischemic events resulted in greater relative oxidative damage for males than for females (Wagner et al., 2004) .
FUNCTIONAL AND PSYCHOLOGICAL
OUTCOMES The goal of any TBI patient is to recover to his or her previous state of health prior to injury; unfortunately, this is not the case with many TBI patients. For future therapies and rehabilitation, it will be important to understand the functional and psychological differences in how males and females are affected by TBI. In a meta-analysis of eight studies that examined TBI and gender, outcomes were worse for females in 17 of the 20 outcome variables assessed; the data showed that females were significantly more prone to suffer from depression, anxiety, headaches, and impaired memory in comparison with males (Farace and Alves, 2000) . However, the authors note that only a small percentage of TBI literature was included because very few studies analyze sex as a variable and compare male and female outcomes. Ratcliffe et al. (2007) studied 325 patients at 1 year after TBI and found that females had better cognitive recovery than males (Ratcliff et al., 2007) . However, as acknowledged by the authors, this study had many limitations, including lack of preinjury cognitive assessment, a lack of noninjured matched controls, and lack of control for localization of brain lesion. Females are more likely to report chronic symptoms such as headache and fatigue and are at an increased risk of depression and anxiety after TBI, yet women in the general population are also at increased risk of depression and anxiety and have a higher incidence of migraine (Colantonio et al., 2010; Scott et al., 2015) . Colantonio et al. (2010) performed a retrospective cohort study on long-term function after moderate to severe TBI in 306 patients aged 14 years and older. They found that four of the five most often reported symptoms-including being forgetful, irritability, poor balance, and word finding difficulties-were the same for men and women. However, females reported significantly more headaches and dizziness than males, whereas males had significantly higher reported rates of hearing/noise difficulties and sleep disturbances (Colantonio et al., 2010) . Similarly, Farace and Alves (2000) found higher rates of hearing disturbances among men than women. In a study of the association between adult psychosocial function and history of childhood TBI, Scott et al. (2015) found that females had significantly higher rates of major depressive disorder than males in the moderate to severe TBI group but not in the mild TBI or orthopedic injury control group. Females were also over eight times more likely than males to report symptoms consistent with anxiety after moderate to severe TBI. Males were found to exhibit higher rates of externalizing behaviors, such as substance abuse and offending behavior (Scott et al., 2015) . A study of orbitofrontal cortex (OFC)-an area of the brain closely interconnected with the amygdala and limbic system, with key roles in executive function and emotional regulation-and functional connectivity in male and female veterans after TBI showed differences in connection patterns after injury (McGlade et al., 2015) . Specifically, males showed connection patterns in the OFC associated with increased physical aggression and revenge planning (McGlade et al., 2015) .
SEX DIFFERENCES IN PRECLINICAL OUTCOMES: SEX HORMONES
The neuroprotective effects of female hormones, estrogen and progesterone, have been extensively studied in animals (Roof and Hall, 2000a,b; Hirschberg, 2008; Mannix et al., 2014) . The potential therapeutic effects of estrogen and progesterone are beyond the scope of this Review, but they have been well studied in humans and animals. It is worth noting that, although many preclinical studies have indicated a multitude of positive benefits for progesterone treatment post-TBI, from decreased inflammation and cerebral edema to increased functional skills in rats, a recent meta-analysis of seven randomized clinical control trials (six of which included a representative female population) failed to demonstrate a significant mortality difference between the progesterone-treated group and the placebo group and concluded that progesterone did not improve outcomes over placebo after TBI (Hirschberg, 2008; Lin et al., 2015) . One reason for this discrepancy between preclinical and clinical outcomes probably lies in the heterogeneous nature of human TBI, which is more complex and variable than in laboratory models (Wright et al., 2015) . However, the possibility that circulating sex hormones could be neuroprotective only further amplifies the importance of including female animals in preclinical research (Tucker et al., 2015; Wright et al., 2015) .
NEURAL SIGNALING POST-TBI
Beyond the sex hormones, several important differences between males and females with respect to TBI have been noted in preclinical studies. Cerebral autoregulation is a homeostatic mechanism that regulates cerebral blood flow (CBF) and can be impaired after TBI, leading increased intracranial pressure (ICP) and poorer outcomes. Studies in newborn piglets suggest that cerebral autoregulation is more impaired in males than in females after TBI, possibly because of a greater upregulation of the extracellular signal-regulated kinase (ERK) isoform of a family of mitogen-activated protein kinases (MAPKs) and interleuklin (IL)-6 in males (Tontisirin et al., 2007; Armstead et al., 2010) . Furthermore, male piglets respond differently than female piglets to different vasopressors, key clinical tools for increasing mean arterial pressure (MAP) and, thus, ensuring adequate CBF (Armstead et al., 2016) . Phenylephrine worsened cerebrovascular dysregulation in male piglets but protected cerebral autoregulation in female piglets (Armstead et al., 2010) . Norepinephrine had no effect on male autoregulation, whereas it protected female autoregulation; furthermore, norepinephrine augmented IL-6 upregulation in males and inhibited IL-6 upregulation in female piglets (Armstead et al., 2016) . Dopamine was found to protect Ley et al. (2013) Mortality in children 1. Prepubescent: No advantage for females over males 2. Postpubescent: Advantage for females over males Phelan et al. (2007) Mortality in children 1. Pre-and peripubescent: No advantage for females over males in mild, moderate, and severe TBI 2. Postpubescent: Significant advantage for females over males in severe TBI; no advantage for females over males in mild or moderate TBI cerebral autoregulation and block upregulation of ERK MAPK in male and female piglets equivalently (Armstead et al., 2013) . These studies indicate that there may be significant differences in the mechanism of cerebral autoregulation after TBI and subsequent response to vasopressors between sexes, which could dramatically alter treatment paradigms. Gunther et al. (2015) , using a penetrating brain injury model, found that male rats had an increased COX-2 response compared with females at 24 and 72 hr, which was associated with increased inflammation. Furthermore, inducible nitric oxide synthase (iNOS) expression in the perilesional area was significantly higher in female rats than in males, but there was no difference in iNOS expression in the ipsilateral cortex or contralateral side between sexes (Gunther et al., 2015) . Suzuki et al. (2000) demonstrated that female rats had smaller contusion volumes and greater numbers of cortical neurons present than male rats after TBI. Furthermore, they reported that males and females respond differently to posttraumatic hypothermia after TBI; overall contusion volume was significantly reduced in males but not in females (Suzuki et al., 2003) . This finding is especially important because the debate about the clinical benefits of therapeutic hypothermia continues, with recent randomized control trials in adults and children actually that suggesting hypothermia could cause more harm than benefit (Saxena et al., 2014; Andrews et al., 2015; Maekawa et al., 2015) . However, these trials, like many others in TBI research, failed to separate and analyze sex differences, which the data from Suzuki et al. (2003) suggest could be a critical element in the role of therapeutic hypothermia in TBI.
INFLAMMATORY MARKERS

THERAPEUTIC HYPOTHERMIA
FUNCTIONAL OUTCOMES
Studies of differences in functional outcome between male and female animals after TBI are lacking; however, Tucker et al. (2015) attempted to address this issue and assessed the long-term sex-specific effects of injury on function in male and female mice. They found that cognitive and motor impairments post-TBI, as measured by Morris water maze and rota-rod, respectively, did not significantly differ between male and female mice (Tucker et al., 2015) . However, spatial working memory, assessed in the y-maze, was poorer in female mice, but they were more active than males. The authors concluded that both sexes should be included in translational research without concern for the effect of hormones on functional outcome or behavior (Tucker et al., 2015) . It is important to note that the female mice were at random and undetermined stages of the estrous cycle in this study; a recent meta-analysis concluded data obtained from female mice at random stages of the estrous cycle had no greater variability than data collected from male mice (Prendergast et al., 2014) .
SEX DIFFERENCES IN MICROGLIA AND DEVELOPMENT OF THE NORMAL BRAIN
Under homeostatic conditions, microglia, the highly mobile resident immune cells of the CNS, constantly survey their surrounding milieu and can play a neuroprotective role via phagocytosis of necrotic cells and debris (Kalla et al., 2001; Davalos et al., 2005; Nimmerjahn et al., 2005) . Microglia have been extensively studied for their role in much neurologic pathology, TBI included. TBI disrupts the delicate architecture of the CNS, leading to microglial activation, which can initially be neuroprotective (Kalla et al., 2001 ). However, in human and rodent studies, TBI has been shown to cause prolonged microglia activation, which can result in a pathologic proinflammatory state, leading to worse functional outcomes (Aloisi, 2001; Ramlackhansingh et al., 2011; Bedi et al., 2013) . Microglia are a prime target for many therapies aimed at dampening the secondary inflammatory response after TBI (Bedi et al., 2013; Savitz and Cox, 2016) . Thus, sex differences in microglial morphology, function, and response to TBI are crucial to evaluating the efficacy, on a cellular and clinical level, of any therapy aimed at attenuating microglia-induced inflammation.
Microglia play an important role in the developing brain, including sexual differentiation (Lenz and McCarthy, 2015) . Recent evidence has demonstrated that microglia differ in quantity and phenotype between female and male rodents in many regions of the brain, including the preoptic area (POA), hippocampus, parietal cortex, and amygdala (Mouton et al., 2002; Schwarz et al., 2012; Lenz et al., 2013; McCarthy et al., 2015) . Lenz et al. (2013) showed that female rat pups had fewer microglia and fewer microglia with an activated morphology in the POA, a region of the brain associated with expression of male sexual behavior (Lenz et al., 2013 ; see their Fig. 2) . Furthermore, they demonstrated that microglia and sex hormones combine to play an interwoven role during the development of the POA. Estradiol causes upregulation of PGE2, with microglia amplifying PGE2 signaling, leading to induction of a masculine dendritic spine phenotype and subsequent male sexual behavior (Lenz et al., 2013 ; see their Fig. 3) . In this pathway, microglial activation is absolutely necessary for sexual differentiation; in pups treated with minocycline, a microglial activation inhibitor, there was no induction of a masculine dendritic spine phenotype in the POA (Lenz et al., 2013) . Although this pathway is specific to one region of the brain examined in neonatal rat pups, it demonstrates the interconnectedness of microglia, sex hormones, and neuroanatomy. Mouton et al. (2002) examined the hippocampus of mice, specifically the dentate gyrus (DG) and CA1 region, and found that females had between a 30% and a 38% increase in number of microglia over their age-matched male counterparts across three different age groups. Crain et al. (2013) analyzed microglial basal gene expression differences in healthy male and female mice brains, from ages 3 days to 12 months. At 3 days, microglia from female brains expressed higher levels of inflammatory cytokines, such as iNOS and tumor necrosis factor-a (TNF-a), than male brains; however, there were no differences in cytokine expression between male and female microglia at any other time evaluated, nor were there differences in microglial estrogen receptor (ER) expression at any time point (Crain et al., 2013) .
The dichotomous role of microglia in normal male and female brain anatomy and development suggests that microglia may not behave exactly the same in both sexes after TBI. The potential differences in male and female microglia, in both normal and pathologic CNS, could be a key factor in outcome differences between the sexes after TBI and deserves further study.
SEX DIFFERENCES IN MICROGLIAL
ACTIVATION AND TBI TBI is a heterogeneous disease associated with heterogeneous outcomes that vary by individual and, as demonstrated by recent research outlined above, by sex. Microglia play a central role in the secondary proinflammatory and pathologic responses after TBI, leading to disruption of the blood-brain barrier and increased cerebral edema. Continued microglial activation for hours, days, and possibly up to years after the initial injury is believed to contribute to worsening pathology and outcomes (Ramlackhansingh et al., 2011) . Microglia have sexually dimorphic roles in development and maintenance of the normal brain, so it stands that microglia have differing responses and roles in TBI between males and females. In a stroke model, Bodhankar et al. (2015) found that microglia from female mice had a lower inflammatory status than male mice after middle cerebral artery occlusion. Furthermore, preclinical studies of ischemia-reperfusion models in rats have demonstrated that treatments with sex steroids-17b-estradiol and progesterone-can suppress microglial activation and downregulate associated proinflammatory cytokines in male and ovariectomized females to a similar extent (Dang et al., 2011; Chen et al., 2014) .
Treatment with lipopolysaccharide (LPS) is known to cause microglial activation in cell culture and, although not an exact replica of TBI, has been used to study sex differences in microglia cells and their interactions with sex hormones (Bruce-Keller et al., 2007 , Loram et al., 2012 Pyter et al., 2013) . Bruce-Keller et al. (2000) found that treatment with 17b-estradiol after LPS stimulation had significant dose-dependent anti-inflammatory effects on microglial activation in vitro via an estrogen receptor (ER)-dependent activation of MAPK, although the exact mechanism was unclear. Although this study failed to specify whether the microglial cells were isolated from male or female rats, it demonstrates the influence that sex hormones might have on the microglial response after TBI. Loram et al. (2012) examined sex differences in microglial activation and treatment with estradiol (E2) after LPS stimulation in neonatal and adult mice. Male neonatal microglia had a significantly greater IL-1b (a cytokine marker of inflammation) response to LPS compared with neonatal females (Loram et al., 2012) . Coincubation of E2 with LPS potentiated the expression of IL-1b mRNA in neonatal female microglia but had anti-inflammatory effects in male neonatal microglia cultures, suppressing IL-1b mRNA expression (Loram et al., 2012) . The response in adult mice was more complicated: LPS-induced IL-1b mRNA was attenuated by E2 in female but not male adult hippocampal microglia ex vivo; however, in vivo, females supplemented with E2 had a potentiated IL-1b response after LPS stimulation (Loram et al., 2012) .
Although the data are limited, microglia may have sex-specific responses to TBI in animal models. Gunther et al. (2015) demonstrated sex differences in COX-2 regulation after a penetrating brain injury in male and female rats; however, they found no difference in microglial activation between sexes in the perilesional area or contralateral side. There is conflicting evidence about the influence of sex hormones on the microglial response after TBI (Barreto et al., 2007 (Barreto et al., , 2014 Bruce-Keller et al., 2007; Acaz-Fonseca et al., 2015) . Barreto et al. (2007) treated orchidectomized male rats with testosterone, estradiol, or dihydrotestosterone (DHT) at either 0-2 days or 5-7 days after a cortical stab wound; they found significantly decreased volume fractions of immunoreactive microglia in the hippocampus of male rats treated with testosterone or estradiol at both treatment times and in animals that received early DHT administration. The authors concluded that testosterone may be converted into estradiol within the CNS and have direct effects on microglia, which have been shown to have estrogen-b receptors in nonhuman primates (Takahashi et al., 2004; Barreto et al., 2007) . In a different study, Barreto et al. (2014) demonstrated that the selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen reduced microglial activation in ovariectomized young and aged female rats after a penetrating brain injury, again providing evidence that sex hormones are important mediators of the microglial response after TBI. Acaz-Fonseca et al. (2015) used a cortical stab model in gonadally intact male and female mice to examine sex differences in microglia and neuroinflammation. They found that male mice had a significantly greater density of Iba-1-positive microglial cells at the lesion border than females (their Fig. 4) . This difference in number was due to higher number of nonreactive microglia, thought to be neuroprotective in TBI, in males compared with females (Acaz-Fonseca et al., 2015; their Fig. 4) . Furthermore, male mice had a significantly higher number of neurons at the lesion border than females, with similar neuronal densities on the contralateral side (Acaz-Fonseca et al., 2015) . In this study, however, the differences in microglial activation between male and female mice was seen only at the lesion border, and the authors concluded that differences in local levels of sex hormones in the injured cortex, and not circulating hormonal levels, contributed to this sexually dichotomous response.
However, Bruce-Keller et al. (2007) reported conflicting data and did not find a difference in cortical tissue sparing among males, intact females, ovariectomized females, and ovariectomized females with estrogen supplementation in a controlled cortical impact model, suggesting that the amount of estrogen in female subjects did not alter injury severity. Microglial activation in the hippocampus was similar between males and females and was not affected by basal levels of estrogen or estrogen supplementation in their model (Bruce-Keller et al., 2007) . Overall, the authors conclude, these data do not support a role, protective or harmful, for sex hormones in TBI. Altogether, these data present a complicated, conflicting, and incomplete picture of sex differences in microglial activation after TBI. A summary of the studies that compared male and female microglia and TBI can be found in Table II . Neonatal and adult mouse microglia cell cultures demonstrated nearly opposite results when comparing the sexes and cytokine expression after TBI; two different SERMs with opposing effects on peripheral estrogen receptors had similar effects on microglial activation; and one study showed that neither sex nor amount of estrogen present had any effect on microglia activation.
Unfortunately, the data for sex differences in human microglia and the inflammatory response after TBI are lacking; however, recent advances in imaging that allow researchers to visualize microglial activation in vivo could provide valuable insight into in the relationship among sex, TBI, and microglia (Ramlackhansingh et al., 2011; Savitz and Cox, 2016) .
CONCLUSIONS
Differences between males and females affected by TBIincluding the role of sex hormones, responses to various therapies, and functional and psychological outcomes-certainly appear probable and, therefore, critical to address and include in future research. On the whole, although males account for the majority of TBI morbidity and mortality, females still make up a significant percentage of the TBI population and must be better represented in the research. The fact that many the data presented above are in conflict with each other underscores the high probability that sex differences in TBI do exist and that more directed study is required. TBI is complex, heterogenous, and variable for each patient; excluding sex as a complex variable in the pathophysiology of TBI would certainly be an oversight. Furthermore, not accounting for sex in evaluating the efficacy of clinical therapies could be harmful to patients and detrimental to understanding the true outcomes of such studies.
In addition, more data are certainly necessary before any definite conclusion about the relationship among sex, sex hormones, and microglia after TBI can be reached. However, it will be an important relationship to continue to study as microglia become increasingly important targets for potential TBI therapies.
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